Polar Capital Holdings Plc - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto Prev, 0, 1
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-02-13
09:41 am
Purchase
2023-12-3113GCELLDEX THERAPEUTICS INC C
CLDX
Polar Capital Holdings Plc3,135,871
5.730%
3,135,871increase
(New Position)
Filing
History
2024-02-13
09:40 am
Purchase
2023-12-3113GAVADEL PHARMACEUTICALS PLC SPO
AVDL
Polar Capital Holdings Plc6,751,782
7.510%
4,251,782increase
(+170.07%)
Filing
History
2024-02-13
09:39 am
Purchase
2023-12-3113GSPYRE THERAPEUTICS, INC
SYRE
Polar Capital Holdings Plc500,000
1.050%
342,552increase
(+217.57%)
Filing
History
2024-02-13
09:39 am
Sale
2023-12-3113GREVANCE THERAPEUTICS INC
RVNC
Polar Capital Holdings Plc3,169,239
3.600%
-1,679,394decrease
(-34.64%)
Filing
History
2024-02-13
09:27 am
Purchase
2023-12-3113GNANOSTRING TECHNOLOGIES INC CO
NSTGQ
Polar Capital Holdings Plc3,975,000
8.260%
196,269increase
(+5.19%)
Filing
History
2024-02-13
09:26 am
Sale
2023-12-3113GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Polar Capital Holdings Plc6,297,688
6.670%
-820,256decrease
(-11.52%)
Filing
History
2023-11-16
1:13 pm
Purchase
2023-10-2013GARCUTIS BIOTHERAPEUTICS INC CO
ARQT
Polar Capital Holdings Plc7,117,944
7.560%
7,117,944increase
(New Position)
Filing
History
2023-07-28
09:01 am
Purchase
2023-07-1913GAEGLEA BIOTHERAPEUTICS, INC. C
AGLE
Polar Capital Holdings Plc157,448
5.020%
157,448increase
(New Position)
Filing
History
2023-07-13
1:43 pm
Unchanged
2022-12-3113GNANOSTRING TECHNOLOGIES INC CO
NSTGQ
Polar Capital Holdings Plc3,778,731
8.100%
0
(Unchanged)
Filing
History
2023-02-14
4:03 pm
Sale
2022-12-3113GSUMMIT THERAPEUTICS INC
SMMT
Polar Capital Holdings Plc0
0.000%
-6,295,713decrease
(Position Closed)
Filing
History
2023-02-14
4:02 pm
Purchase
2022-12-3113GREVANCE THERAPEUTICS INC
RVNC
Polar Capital Holdings Plc4,848,633
5.900%
4,848,633increase
(New Position)
Filing
History
2023-02-14
4:01 pm
Sale
2022-12-3113GQUOTIENT LIMITED
QTNT
Polar Capital Holdings Plc0
0.000%
-231,291decrease
(Position Closed)
Filing
History
2023-02-14
4:00 pm
Purchase
2022-12-3113GNANOSTRING TECHNOLOGIES INC CO
NSTGQ
Polar Capital Holdings Plc3,778,731
8.100%
3,778,731increase
(New Position)
Filing
History
2023-02-14
3:59 pm
Sale
2022-12-3113GINFINITY PHARMACEUTICALS INC C
INFIQ
Polar Capital Holdings Plc2,071,242
2.300%
-2,928,758decrease
(-58.58%)
Filing
History
2022-02-14
10:58 am
Sale
2021-12-3113GAVADEL PHARMACEUTICALS PLC SPO
AVDL
Polar Capital Holdings Plc2,500,000
2.400%
-294,673decrease
(-10.54%)
Filing
History
2022-02-14
10:47 am
Purchase
2021-12-3113GSUMMIT THERAPEUTICS INC
SMMT
Polar Capital Holdings Plc6,295,713
6.400%
495,713increase
(+8.55%)
Filing
History
2022-02-14
10:46 am
Unchanged
2021-12-3113GQUOTIENT LIMITED
QTNT
Polar Capital Holdings Plc231,291
9.040%
0
(Unchanged)
Filing
History
2022-02-14
10:46 am
Sale
2021-12-3113GOXFORD IMMUNOTEC GLOBAL PLC
OXFD
Polar Capital Holdings Plc0
0.000%
-2,568,385decrease
(Position Closed)
Filing
History
2022-02-14
10:41 am
Purchase
2021-12-3113GINFINITY PHARMACEUTICALS INC C
INFIQ
Polar Capital Holdings Plc5,000,000
5.600%
5,000,000increase
(New Position)
Filing
History
2022-02-14
10:40 am
Sale
2021-12-3113GAVADEL PHARMACEUTICALS PLC SPO
AVDL
Polar Capital Holdings Plc2,794,673
4.800%
-233,032decrease
(-7.70%)
Filing
History
Goto Prev, 0, 1